Oaktree (OCSL) Q4 2026 Earnings Call Transcript

Source Motley_fool
Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Tuesday, Nov. 17, 2026

CALL PARTICIPANTS

  • Head of Investor Relations - Alison Friedman Mermey
  • President - Mathew Pendo
  • Chief Executive Officer and Co-Chief Investment Officer - Armen Panossian
  • Co-Chief Investment Officer - Raghav Khanna
  • Chief Financial Officer and Treasurer - Christopher McKown

TAKEAWAYS

  • Adjusted Net Investment Income -- $29.6 million or $0.34 per share for the quarter, reflecting lower average portfolio balances and higher income-based incentive fees.
  • Nonaccrual Rate -- 1.8% of the total debt portfolio at fair value, representing a 120-basis-point reduction from 3.0% a year ago.
  • Nonaccrual Fair Value -- $45 million at the end of the fiscal year, representing a 44% decrease from $81 million at the end of fiscal 2025.
  • Unsecured Note Issuance -- $300 million of five-year notes with a 7% coupon, priced at a spread of 240 basis points over U.S. treasuries to extend the debt maturity profile.
  • Net Debt-to-Equity Ratio -- 1.00x as of Sept. 30, positioned at the midpoint of the company's long-term target range of 0.9x to 1.25x.
  • Liquidity Position -- $1.04 billion at quarter end, including $45.1 million in cash and $994 million in undrawn credit capacity.
  • Pro Forma Liquidity -- $689 million after adjusting for the repayment of upcoming January 2027 notes.
  • Quarterly Distribution -- $0.32 per share total, composed of a $0.30 base dividend and a $0.02 supplemental dividend.
  • Weighted Average Portfolio Yield -- 9.4% on debt investments, compared to 9.3% in the prior fiscal quarter.
  • New Investment Commitments -- $178.5 million during the fourth fiscal quarter, driven by 12 new portfolio company investments and nine follow-on investments.
  • Exits and Prepayments -- $197.8 million in total proceeds, including the full repayment of a $35 million loan to RumbleOn.
  • First-Lien Exposure -- 79.1% of the portfolio at fair value, while equity investments increased to 5.5% of fair value.
  • Interest Coverage -- 2.3x weighted average for borrowers, which management indicated would remain at 2.1x under a 100-basis-point rate increase scenario.
  • Software Sector Concentration -- 20% of the portfolio at fair value, with AI-related risk exposure estimated at approximately 3%.
  • Part I Incentive Fees -- $4.8 million for the quarter, net of a $1.2 million reduction resulting from the total return hurdle.
  • Total Return Fee Reductions -- $16.1 million in incentive fees waived or reduced over the last year to align manager earnings with shareholder returns.
  • Net Asset Value -- $15.63 per share as of Sept. 30, down 0.4% sequentially from $15.70.
  • Payment-in-Kind Income -- 7.3% of adjusted total investment income, representing a decrease from 7.8% in the prior quarter.
  • Joint Venture Performance -- 11.5% aggregate return on equity for the two joint ventures, which held $547 million in total investments.
  • Unfunded Commitments -- $225.5 million excluding joint ventures, with $224.6 million available for immediate funding.
  • October Pipeline -- $80 million in new investment commitments originated during the month following quarter end.
  • Median Portfolio EBITDA -- $180 million for the 170 companies in the portfolio, with a weighted average leverage of 5.1x.
  • Floating Rate Exposure -- 91% of debt investments, providing sensitivity to interest rate changes as loans reset.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

  • Raghav Khanna stated, "We added the first-out term loan of Pluralsight to non-accrual as the company continues to underperform expectations," noting that the second-out loan was already on nonaccrual status.
  • Armen Panossian stated, "markets saw increased volatility in early 2026 amid concerns of AI disruption, geopolitical uncertainty and renewed inflation pressures," describing the shifting macroeconomic backdrop.
  • Armen Panossian noted that "the weakest leverage credit lagged, reflecting increasingly selective investor appetite and the growing strain of elevated borrowing costs," as credit market outcomes were uneven.

SUMMARY

Oaktree Specialty Lending (NASDAQ:OCSL) management emphasized debt reduction and balance sheet flexibility as key achievements for the fiscal year. The company reduced its nonaccrual exposure by 44% in dollar terms through successful credit workouts and proceeds from repayments. Management successfully accessed the debt markets with a $300 million unsecured bond offering, extending its maturity profile and maintaining leverage at the midpoint of its target range. The portfolio remains centered on senior secured lending, with first-lien debt making up nearly 80% of total investments and a focus on larger, resilient companies with median EBITDA of $180 million.

  • CEO Panossian noted that the premium for direct lending originations over broadly syndicated loans widened to more than 150 basis points during the quarter.
  • CFO McKown stated, "Beginning in the December quarter, the September rate hike will start to flow through to net investment income," with every 25-basis-point increase adding over $0.05 per share per quarter to adjusted net investment income.
  • Management reported that BioXcel Therapeutics received FDA approval for its drug on Nov. 13, triggering a $67.5 million milestone payment to lenders.
  • President Pendo stated, "nearly 85% of the decline in non-accrual dollars over the past year came from proceeds received and investments returning to accrual status."
  • The company anchored a GBP 600 million first-lien facility for Outcomes First Group, a U.K.-based provider of schools for children with special educational needs.
  • Raghav Khanna noted that current nonaccrual additions are driven by idiosyncratic reasons, such as revenue collection issues at a treatment center business, rather than broader cyclical themes.

INDUSTRY GLOSSARY

  • BDC: Business Development Company, a type of closed-end investment company that invests in small and mid-sized businesses.
  • Nonaccrual: A status given to loans where the borrower is no longer making scheduled interest or principal payments.
  • SOFR: Secured Overnight Financing Rate, a benchmark interest rate for dollar-denominated derivatives and loans.
  • First-Lien Debt: Debt that has the first claim on a borrower's assets or cash flows in the event of a liquidation.
  • PIK: Payment-in-kind, a type of interest that is paid with additional debt rather than cash.
  • EBITDA: Earnings before interest, taxes, depreciation, and amortization, a measure of operating performance.
  • OID: Original issue discount, the difference between the stated par value of a bond and the price at which it was issued.
  • SONIA: Sterling Overnight Index Average, the effective overnight interest rate for British pound transactions.

Full Conference Call Transcript

Operator: Welcome, and thank you for joining Oaktree Specialty Lending Corporation's Fourth Fiscal Quarter 2026 Conference Call. Today's conference is being recorded. [Operator Instructions] I will now turn the call over to Alison Mermey, OCSL's Head of Investor Relations. Please go ahead.

Alison Friedman Mermey: Thank you, operator. Our fourth fiscal quarter and full year 2026 earnings release, which we issued this morning, along with the accompanying slide presentation, can be accessed on the Investors section of our website, oaktreespecialtylending.com. Before we begin, I want to remind you that the comments on today's call include forward-looking statements reflecting current views with respect to, among other things, future operating results and financial performance. Actual results could differ materially from those implied or expressed in the forward-looking statements. Please refer to the relevant SEC filings for a discussion of these factors in further detail. Oaktree undertakes no duty to update or revise any forward-looking statements.

I'd also like to advise you that nothing on this call constitutes an offer to sell or solicitation of an offer to purchase any interest in an Oaktree fund. Investors and others should note that OCSL uses the Investors section of its corporate website to announce material information. The company encourages investors, the media and others to review information that it shares on its website. On today's call, Matt Pendo, President of OCSL, will begin with a progress report on fiscal 2026 priorities and an overview of our fourth fiscal quarter results. Armen Panossian, CEO and Co-Chief Investment Officer, will then provide a market update.

Raghav Khanna, Co-Chief Investment Officer, will cover portfolio activity; and Chris McKown, CFO and Treasurer, will close with a review of our financial results before we open the call for questions. Now I'll turn the call over to Matt Pendo, President of OCSL. Matt?

Mathew Pendo: Thank you, Alison, and good morning, everyone. I would like to begin by reflecting on the progress we've made against our 2 main priorities from this past year: number one, reducing non-accruals; and number two, keeping our balance sheet flexible. I'll then cover our financial highlights and our dividend. Starting with non-accruals. At the end of our fiscal year, non-accruals were approximately 1.8% of the total debt portfolio at fair value. This was down about 120 basis points from a year ago and relatively unchanged from June. In dollar terms, non-accruals at fair value have fallen from $81 million a year ago to $45 million today, a reduction of 44%.

Importantly, nearly 85% of the decline in non-accrual dollars over the past year came from proceeds received and investments returning to accrual status. We believe this reflects our team's ability to successfully work through challenging credits. Raghav will walk through additional updates to non-accrual positions in his remarks. There were several positive developments to our balance sheet this quarter, including an update to our ratings outlook and a bond offering. First, in August, Moody's revised our outlook to stable and kept our Baa3 rating unchanged. Second, in September, we priced $300 million of 5-year unsecured notes due 2031 with a 7% coupon and a spread of 240 basis points over U.S. treasuries.

After swapping the floating rate, the equivalent spread to SOFR is 258 basis points. This was our first bond issuance in over a year, and we were pleased with the outcome in a choppy market backdrop. Demand was strong with a final order book more than 3x the size of the deal and included new OCSL bond investors. We want to thank the fixed income community for their support on this transaction. The incremental cost of the new financing is less than $0.05 per share per quarter. After the January 2027 notes are repaid at maturity using borrowings under our revolving credit facility, we will be left with a well-staggered maturity profile, and our next debt maturity is February 2029.

We maintained conservative leverage during the quarter, ending September 30 at 1.00 net debt to equity. Over the course of fiscal year 2026, we maintain net leverage between 0.97x and 1.07x, well inside the long-term target range of 0.9x to 1.25x. Liquidity was approximately $1.04 billion at quarter end. That figure is temporarily elevated because the January notes have not yet been repaid. Pro forma for that repayment, liquidity is approximately $689 million, in line with last quarter and a year ago. Turning to financial highlights for our fourth fiscal quarter and fiscal year. Adjusted net investment income was $29.6 million or approximately $0.34 per share, down from $32.2 million or $0.37 per share in the prior quarter.

This decrease primarily reflected a lower average portfolio balance and a higher income-based incentive fee. For the full fiscal year, adjusted net investment income was $131.7 million or $1.49 per share compared to $151.3 million or $1.76 per share for the 2025 fiscal year. Now turning to the dividend. Our Board declared a total cash dividend of $0.32 per share for the quarter, composed of a base cash dividend of $0.30 per share and a supplemental dividend of $0.02 per share. The dividends are payable in cash on December 31, 2026, to stockholders of record on December 15, 2026.

As a reminder, we adjusted the base dividend in May to be covered by earnings at our current conservative leverage and maintain the supplemental dividend equal to 50% of adjusted net investment income in excess of the base dividend. Dividends declared in fiscal 2026 totaled $1.39 per share, which represented 108% of adjusted net investment income. As we look to fiscal 2027, our top priorities are unchanged: resolve non-accruals, exit non-income-producing equity positions and redeploy those proceeds into performing assets. With net leverage of 1.00x and nearly $700 million of pro forma liquidity, we have the flexibility to be opportunistic as new investments and strategic opportunities arise.

With that, I'll turn the call over to Armen to discuss the market environment.

Armen Panossian: Thank you, Matt. Since this is a fiscal year-end call, I want to compare where we stood a year ago with where we are today. Last year, the Fed had just cut rates in September and October, and the market expected additional rate cuts in 2026, along with an upswing in M&A activity. Neither of those predictions materialized. Instead, markets saw increased volatility in early 2026 amid concerns of AI disruption, geopolitical uncertainty and renewed inflation pressures. It's a good reminder of why Oaktree's investment philosophy is tied to fundamental credit analysis rather than macro forecasting.

Fast forward to today, with Brent crude rising above $100 per barrel during the September quarter and large AI-related CapEx adding to inflation pressures, the Fed instead raised rates by 25 basis points. That put the federal funds rate at 3.75% to 4% and the 10-year treasury yield moved above the symbolic 5% threshold, reaching its highest level in nearly 2 decades. A year ago, the debate was how far rates would fall. Today, it is how long they stay high and how high.

Our view is that a move in short-term base rates from approximately 4% to 5% would remain manageable and could be beneficial to investor returns as most of the increase would flow through to net investment income. For OCSL, 91% of our debt investments are floating rate and a higher base rate increases contractual interest income as loans reset. The other important factor is whether our borrowers can withstand higher rates. We assess each borrower's interest coverage across a range of base rate scenarios and build cushion into the capital structure at underwriting. Based on our borrowers' last 12 months of results, weighted average interest coverage is 2.3x.

If base rates rose by 100 basis points, coverage would still be about 2.1x, above the roughly 1.9x trough our portfolio experienced in late 2023 and early 2024. Against the change in the rate backdrop, credit market outcomes in the quarter were uneven. U.S. leveraged loans returned nearly 2%, supported by floating rate coupons that limit sensitivity to rising rates, while high-yield bonds declined by almost 2% as treasury yields rose. Corporate fundamentals remain broadly resilient, but the weakest leverage credit lagged, reflecting increasingly selective investor appetite and the growing strain of elevated borrowing costs. On deal activity, direct lending volume rebounded slightly in September, although year-to-date deal flow and average deal size remained below that of last year.

Capital is still competitive for most transactions despite a pullback from many of the largest nontraded BDCs, meaning supply and demand are relatively balanced. Spreads on new sponsor-backed first lien loans held at SOFR plus 500 to 550 basis points for several months, about 50 to 100 basis points wider than that at the end of 2025. As the broadly syndicated loan market continued to tighten in the quarter, the premium that direct lending new originations offered over new broadly syndicated loans widened to over 150 basis points. Putting it together, we remain focused on what we can control, and we feel well positioned even in a higher for longer and more volatile environment.

With that, I will turn the call over to Raghav for a review of our investment activity and portfolio.

Raghav Khanna: Thank you, Armen. I'll start with new originations and exits, then discuss non-accruals before closing with portfolio metrics. Turning to originations. New investment commitments totaled $179 million in the quarter compared with $206 million last quarter and $208 million in the fourth fiscal quarter of 2025. We have seen our pipeline build steadily since late September and originated about $80 million of new investment commitments in October. Weighted average yield on new debt investments during the quarter was 9.6%, with a spread on new originations of about 570 basis points, wider than the market spread range of 500 to 550.

One notable deal during the quarter was a first lien loan to Outcomes First Group, which appears as OFS Bidco on our schedule of investments. Outcomes First Group is the U.K.'s largest independent provider of schools for children and youth with special educational needs and disabilities. The total facility consisted of GBP 600 million of first lien debt with about 75% funded upfront, priced at SONIA plus 525 basis points with 1.5 points of OID. The transaction refinanced the company's existing debt and supports further expansion, including internationally. Oaktree's long-standing relationship with the sponsor, TPG, positioned Oaktree as the anchor lender.

The investment was underwritten and structured by our European private debt team that has deep local market knowledge and direct engagement with the management team. We like the company due to its long operating history, hard-to-replicate footprint, high quality of schools and strong revenue visibility. It also operates in an industry with several demand tailwinds that includes statutory funding obligations, a persistent structural supply shortage and high barriers to entry. This deal demonstrates the value of combining on-the-ground presence and regional expertise with global relationships. During the quarter, we also participated in 3 performing equity investments that increased our equity exposure to 5.5% of fair value from 3.9% last quarter.

These income-producing equity deals are highly structured with negotiated downside protection and offer compelling risk-adjusted returns for our portfolio. Moving now to exits and prepayments. Proceeds from prepayments, exits, other paydowns and sales were $198 million compared with $263 million last quarter and $177 million last year. We were repaid in full on several private investments during the quarter. Some borrowers were taken out in the broadly syndicated loan market and some were refinanced by other private lenders. A notable exit in the quarter was the repayment of our first lien term loan in RumbleOn, which appeared in our schedule of investments as RideNow Group, a publicly traded company that operates powersports retail dealerships and an e-commerce business.

We were the agent on the term loan, which originally funded in 2021 to finance RumbleOn's acquisition of the RideNow powersports platform. Integration challenges and weaker post-COVID consumer spending pressured EBITDA and put covenant compliance at risk, leading us to mark the loan down to 94% in the year 2023. Importantly, our highly structured loan prevented value leakage during the company's period of underperformance, and we worked collaboratively with the company on a turnaround plan involving new management, cost reductions, asset sales and capital raises.

These actions reposition the company for growth, and we were willing to provide relief to the company in the form of covenant resets and a maturity extension in exchange for debt paydowns during this time to rightsize the balance sheet. In September, RumbleOn refinanced its term loan and our remaining $35 million position was repaid at 101, including an exit fee, a year ahead of the 2027 maturity. This is another example of how our focused structuring capabilities, patience, collaboration with management teams and discipline yielded a positive outcome for OCSL stakeholders. Turning to non-accruals. At September 30, 6 companies were on nonaccrual, the same as last quarter and down from 10 a year ago.

Non-accruals represented approximately 1.8% of the total debt portfolio at fair value. This also represents 4% of the total debt portfolio at cost, which is down 20 basis points sequentially and 250 basis points from a year ago on a cost basis. One investment came off non-accrual, one new tranche in an existing non-accrual name was added and one new borrower was added. BayMark came off non-accrual following the resolution by lenders to recapitalize and stabilize the business. We added the first-out term loan of Pluralsight to non-accrual as the company continues to underperform expectations. As a reminder, in December 2025, we placed the second our term loan on non-accrual and marked our equity to 0.

The new name added to non-accrual during this quarter is BioXcel Therapeutics, a publicly traded biopharmaceutical company, but we expect a relatively quick resolution in the December quarter. BioXcel entered Chapter 11 in late August 2026 with an up to $125 million stocking horse proposal from Teva, a large global pharmaceutical company. It was a fast-moving court supervised process and in late October, the sale to Teva closed at a value in line with our carrying mark of [ 83 ]. Teva funded $57.5 million upfront at closing with the balance payable upon certain regulatory and commercial thresholds.

We're pleased to say that on November 13, Teva received FDA approval for BioXcel's drug, which has triggered the full $67.5 million additional milestone to the lenders. This is expected to be paid within 30 days and will lead to a realized value well in excess of our carrying mark. Closing out the discussion on non-accruals is an update on Thrasio. As a reminder, last quarter, 80% of the debt was paid down and the small amount that remained was returned to accrual status. In early November, the balance was fully paid down at par. Looking at total portfolio metrics as of September 30, 79.1% of the portfolio at fair value was first lien senior secured debt.

Weighted average yield on debt investments was 9.4% compared with 9.3% last quarter. The portfolio remains well diversified with 170 portfolio companies. The average debt position is approximately 62 basis points of the total portfolio at fair value and no single position exceeds 2.1%. The median EBITDA of our portfolio companies was approximately $180 million. Portfolio company weighted average leverage was 5.1x and the interest coverage was 2.3x, both metrics steady sequentially and compared to a year ago. On software, based on GICS industry group classification, software represents 20% of the portfolio at fair value, steady sequentially and down from 24% a year ago.

94% of our software positions are first lien and ARR-based loans represent just 0.8% of the portfolio. Our high AI risk software exposure remains relatively unchanged at approximately 3% of the performing debt portfolio. And with that, I'll turn the call over to Chris to review our financial results.

Christopher McKown: Thank you, Raghav. In our fourth fiscal quarter ended September 30, 2026, adjusted total investment income was $68.0 million, down from $69.2 million in the prior quarter. The sequential decrease primarily reflected a lower average portfolio balance. Fiscal year adjusted total investment income was $281.4 million compared with $315.4 million in the prior year. The year-over-year decrease was primarily attributable to lower reference rates and a lower average portfolio balance. The year-over-year decrease was primarily attributable to lower reference rates and a lower average portfolio balance. We delivered adjusted net investment income of $29.6 million or $0.34 per share compared with $32.2 million or $0.37 per share in the prior quarter.

The sequential decline was driven by lower total investment income and a higher income-based or Part 1 incentive fee, partially offset by lower interest and other expenses. For the full year, adjusted net investment income was $131.7 million or $1.49 per share compared with $151 million or $1.76 per share in fiscal 2025 with similar performance drivers as the quarterly results. On the incentive fee, we paid $4.8 million this quarter or approximately $0.05 per share compared with $2.4 million last quarter or $0.03 per share. A full quarterly incentive fee would have been approximately $6.0 million. So our total return hurdle reduced the fee by approximately $1.2 million or about $0.01 per share in the September quarter.

For the full year, incentive fee paid was $8.4 million or $0.10 per share. Over the last year, our total return hurdle reduced incentive fees by $16.1 million. We believe the mechanism is working as designed, aligning the fees Oaktree earns with the total returns shareholders receive. Beginning in the December quarter, the September rate hike will start to flow through to net investment income. With 91% of our debt investments floating rate and 100% of our debt floating or swapped to floating, the net impact is positive, all else equal. Although resets are somewhat staggered across the portfolio, we'll see the majority of the impact in our December quarter earnings with the full effect building from there.

Once fully reset, every 25 basis point increase in base rates adds a little over $0.05 per share per quarter to adjusted net investment income with a little over $0.02 per share annualized. Turning to NAV. NAV per share was $15.63 as of September 30, down 0.4% from $15.70 in June. PIK income represented approximately 7.3% of adjusted total investment income during the quarter, down from 7.8% last quarter. Approximately 75% of total PIK income relates to investments that were structured with the option to PIK at origination. Investments generating noncash income during the quarter are marked at a weighted average fair value of approximately 98%.

Our net leverage at quarter end was 1.00x compared with 1.02x last quarter and 0.97x a year ago. Our long-term target leverage range of 0.9x to 1.25x remains unchanged. Total debt outstanding at quarter end was $1.42 billion. As of September 30, the weighted average interest rate on debt outstanding was 6.2% compared with 5.9% last quarter and 6.5% a year ago. Adjusted for the new 2031 notes, paydown of the 2027 notes and a higher base rate, pro forma interest rate on debt is 6.4%. Unsecured debt represented approximately 88% of total debt at quarter end compared with 65% last quarter and 64% a year ago.

Pro forma for the expected repayment of the 2027 notes, unsecured debt would have been approximately 64% of total debt at quarter end. Our liquidity was approximately $1.04 billion, including $45 million of cash and $994 million of undrawn capacity under our credit facilities. Pro forma for the repayment of the 2027 notes at maturity, liquidity would have been approximately $689 million compared with $699 million last quarter and $695 million a year ago. Unfunded commitments, excluding those related to the joint ventures, were approximately $226 million. Ending with our joint ventures. Together, the JVs held approximately $547 million of investments across 144 portfolio companies and generated aggregate returns on equity of approximately 11.5% during the quarter.

Leverage at the JVs was 2.0x compared to 2.1x last quarter. With that, I'll turn the call back to the operator for Q&A.

Operator: [Operator Instructions] We have no questions at this time. I will now turn the call back to Alison for closing remarks. Opening the line again, I would like to re-prompt for questions. [Operator Instructions] Your first question comes from the line of Sean-Paul Adams with B. Riley Securities.

Sean-Paul Adams: It looks like PIK kind of trended down a little bit since the June quarter. Was that due to the restructuring? Or can you guys just walk me through the portfolio changes?

Christopher McKown: Sean-Paul, it's Chris. Thanks for the question. Yes, in terms of the downtick quarter-on-quarter, as mentioned in the prepared remarks, we did move BioXcel to non-accruals. That was part of the impact. We do expect a quick resolution there. And then the other factor, we had a royalty interest that had been picking previously that we exited during the quarter. Those are the 2 big drivers.

Operator: Your next question comes from the line of Ethan Kaye with Lucid Capital Markets.

Ethan Kaye: Just a quick one for me. Can you just kind of review capital allocation priorities? You talked about -- you have some room to kind of bring leverage higher if you want. You talked about remaining kind of flexible on the balance sheet, but just walk through balancing kind of deployment and repurchases and leverage, et cetera.

Mathew Pendo: Ethan, it's Matt. Thanks for the question. So we talk to the Board every quarter about capital allocation. I want to be thoughtful about it. Since we took over management, we have not repurchased shares for a couple of reasons. I think the primary is just desire to have capital to continue to invest in portfolios and attractive loans that we see. So that continues to be kind of priority #1. Over 2026, we ran leverage 0.97 to 1.07. As I mentioned in the call, our target is 0.9 to 1.25. We ended the year at 1x. So we definitely -- and as Chris kind of walked through our liquidity and capital, we have plenty of capital.

So I think our primary focus is to deploy and to attract investment opportunities. We have the capital. We're comfortable taking our leverage up within the range we've done in the last year, 0.97, 1.07. So I think that's where we're going to be focused.

Ethan Kaye: Great. And then I guess one more quick one. I think in the past, you've kind of categorized the credits that have underperformed as maybe businesses that like struggled with post-COVID normalization. It looks like credit performance has stabilized nicely in the last couple of quarters. But curious if you kind of feel like the impact from that -- that kind of trend has subsided largely maybe with the exception of Pluralsight.

Raghav Khanna: Yes. Ethan, I can take that. So you're right, like most of the big declines in '21 and '22 were because of post-COVID normalizations, but also, frankly, a lot of the capital structures that were put in place in 2021 and early 2022 were just not set up for base rates being low 4s to 5. So those were the primary reasons. I think going forward and what you're seeing right now is the non-accruals that -- the one non-accrual that was added, the new name, it's largely because of idiosyncratic reasons. So to give you some color, the name that was added, it's the largest opioid treatment center business in the U.S.

So when you think about the end market, it's not cyclical. And frankly, the revenues have not been cycling. They had an idiosyncratic issue in revenue collection because of bad ERP systems, which is what led to the restructuring. So when we see problems in the portfolio now, they're idiosyncratic as opposed to because of one big theme.

Mathew Pendo: And I think, Ethan, just to follow up. I do think -- and we talked about the call like the progress with BioXcel, I think I still think there's progress we can make on the existing non-accruals.

Operator: We have reached the end of the Q&A session. I will now turn the call back to Alison for closing remarks.

Alison Friedman Mermey: Thank you all for joining us on today's call. Please feel free to reach out to me and the team with any questions. Have a great day, everyone.

Operator: This concludes today's call. Thank you for attending. You may now disconnect.

Should you buy stock in Oaktree Specialty Lending right now?

Before you buy stock in Oaktree Specialty Lending, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oaktree Specialty Lending wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $327,620!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $959,410!*

Now, it’s worth noting Stock Advisor’s total average return is 802% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 17, 2026.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Market News Today Australia: VIX Jumps Nearly 19%, Gold Hits One-Year Low and Nasdaq 100 FallsNasdaq 100 falls 2.67%, gold hits a one-year low and WTI settles at US$85.72. See what Australian traders are watching ahead of Nvidia earnings.
Author  Mitrade Team
22 hours ago
Nasdaq 100 falls 2.67%, gold hits a one-year low and WTI settles at US$85.72. See what Australian traders are watching ahead of Nvidia earnings.
placeholder
Tom Lee Sees No Cracks in the AI Trade Despite Nasdaq's 12% DropTom Lee, head of research at Fundstrat Global Advisors, says the artificial intelligence (AI) trade remains structurally intact. The tech-heavy Nasdaq Composite had fallen nearly 12% from its Oct. 6 r
Author  Beincrypto
21 hours ago
Tom Lee, head of research at Fundstrat Global Advisors, says the artificial intelligence (AI) trade remains structurally intact. The tech-heavy Nasdaq Composite had fallen nearly 12% from its Oct. 6 r
placeholder
Stocks, Gold, and Asia Bleed $2.2 Trillion: Top 5 Factors That Triggered the CrashGlobal markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
Author  Beincrypto
21 hours ago
Global markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
placeholder
Nvidia faces its biggest earnings test yet — why Silicon Valley billionaires want Jensen Huang backNvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
Author  Mark Garro
21 hours ago
Nvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
placeholder
Gold Price Today: Can XAU/USD Hold $3,870? | Mitrade AUGold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
Author  Mitrade Team
15 hours ago
Gold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
goTop
quote